Product/Composition:- | Cyclophosphamide |
---|---|
Strength:- | Injection: 200 mg/2 mL (vial), 500 mg/5 mL (vial); Tablet: 25 mg, 50 mg ,100 mg |
Form:- | Oral Tablet & Injection: |
Reference Brands:- | Cytoxan®(US & EU), Endoxan®(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Cyclophosphamide is an intravenous chemotherapy drug used for breast cancer, ovarian cancer, non-Hodgkin lymphoma, leukemia, and autoimmune diseases. Available in IV (200 mg/2 mL, 500 mg/5 mL) and oral tablet (25 mg, 50 mg, 100 mg) formulations in the US and EU.
Cyclophosphamide, marketed as Cytoxan® (US) and Endoxan® (EU), is a chemotherapy agent widely used in the treatment of cancers such as breast cancer, ovarian cancer, non-Hodgkin lymphoma, leukemia, and multiple myeloma. Additionally, it is used in the treatment of autoimmune diseases, including systemic lupus erythematosus. Available in IV infusion (200 mg/2 mL, 500 mg/5 mL) and oral tablet (25 mg, 50 mg, 100 mg) forms, Cyclophosphamide works as an alkylating agent to disrupt cancer cell DNA, offering significant opportunities for B2B oncology pharmaceutical companies in the US and EU markets.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications